High expression of GEM and EDNRA is associated with metastasis and poor outcome in patients with advanced bladder cancer

Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy

(2014) Jens G. Lohr et al.   CANCER CELL

Comprehensive molecular characterization of urothelial bladder carcinoma

(2014)   NATURE

Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing

(2014) Marco Gerlinger et al.   NATURE GENETICS

Predictors of cancer-specific mortality after disease recurrence following radical cystectomy

(2012) Michael Rink et al.   BJU INTERNATIONAL

Expression of TIP60 (tat-interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment-specific outcome of localised invasive bladder cancer

(2012) Jens R. Laurberg et al.   BJU INTERNATIONAL

Combination of a Novel Gene Expression Signature with a Clinical Nomogram Improves the Prediction of Survival in High-Risk Bladder Cancer

(2012) Markus Riester et al.   CLINICAL CANCER RESEARCH

A Molecular Taxonomy for Urothelial Carcinoma

(2012) G. Sjodahl et al.   CLINICAL CANCER RESEARCH

The GTPase Gem and its partner Kif9 are required for chromosome alignment, spindle length control, and mitotic progression

(2012) Guillaume Andrieu et al.   FASEB JOURNAL

Clonal selection drives genetic divergence of metastatic medulloblastoma

(2012) Xiaochong Wu et al.   NATURE

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

(2012) Marco Gerlinger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Single-cell sequencing analysis characterizes common and cell-lineage-specific mutations in a muscle-invasive bladder cancer

(2012) Yingrui Li et al.   GigaScience

Evaluation of different lymph node (LN) variables as prognostic markers in patients undergoing radical cystectomy and extended LN dissection to the level of the inferior mesenteric artery

(2011) Jørgen B. Jensen et al.   BJU INTERNATIONAL

Meta-analysis of multiple microarray datasets reveals a common gene signature of metastasis in solid tumors

(2011) Marla H Daves et al.   BMC Medical Genomics

High Expression of Karyopherin-α2 Defines Poor Prognosis in Non–Muscle-Invasive Bladder Cancer and in Patients with Invasive Bladder Cancer Undergoing Radical Cystectomy

(2011) Jørgen Bjerggaard Jensen et al.   EUROPEAN UROLOGY

Treatment of Muscle-invasive and Metastatic Bladder Cancer: Update of the EAU Guidelines

(2011) Arnulf Stenzl et al.   EUROPEAN UROLOGY

EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update

(2011) Marko Babjuk et al.   EUROPEAN UROLOGY

Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor–Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype—ACOSOG Z1031

(2011) Matthew J. Ellis et al.   JOURNAL OF CLINICAL ONCOLOGY

International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial

(2011)   JOURNAL OF CLINICAL ONCOLOGY

A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment

(2011) Steven Christopher Smith et al.   LANCET ONCOLOGY

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Polypoid lesions following surgical correction of bladder exstrophy

(2009) E. Kaufman et al.   ENDOSCOPY